Phase Ⅰ,ⅡStudy of Topically Applied Green Tea Extract for Prevention and Treatment of Radio Dermatitis and Radiation Mucositis
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Number of Participants with Adverse Events
participants will be followed for the duration of radiotherapy, an expected average of 6 weeks").
Yes
Jinming Yu, M.D.
Study Director
Shandong Cancer Hospital and Institute
China: Food and Drug Administration
GTERD2011
NCT01481818
September 2011
April 2012
Name | Location |
---|